吉林(lin)敖(ao)東(dong)藥(yao)業集團股(gu)(gu)份有(you)限(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(si)的(de)前身是1957年(nian)成(cheng)(cheng)立(li)的(de)國營(ying)延邊敦化(hua)鹿場，于1981年(nian)建立(li)敖(ao)東(dong)制藥(yao)廠，1993年(nian)3月經(jing)省體改委批準(zhun)(zhun)改制為(wei)吉林(lin)敖(ao)東(dong)藥(yao)業集團股(gu)(gu)份有(you)限(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(si)，1996年(nian)10月28日在深(shen)交(jiao)所掛牌上(shang)市(shi)(shi)。公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(si)現共控股(gu)(gu)5家(jia)(jia)從(cong)事現代(dai)(dai)中藥(yao)、生物化(hua)學藥(yao)和植物化(hua)學藥(yao)的(de)專業制藥(yao)子公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(si)，9家(jia)(jia)醫(yi)(yi)藥(yao)銷售子公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(si)，8家(jia)(jia)醫(yi)(yi)藥(yao)配套子公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(si)，2家(jia)(jia)高端(duan)保健品公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(si)，1家(jia)(jia)公(gong)(gong)(gong)(gong)(gong)路建設收費公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(si)，1家(jia)(jia)敖(ao)東(dong)國際(ji)（香港）實業有(you)限(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(si)，擁有(you)種植、養(yang)殖(zhi)基地，建立(li)了“公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(si)+標準(zhun)(zhun)化(hua)基地+特(te)許農(nong)戶”的(de)產(chan)業鏈經(jing)營(ying)模式，逐步(bu)發展成(cheng)(cheng)為(wei)以(yi)醫(yi)(yi)藥(yao)產(chan)業為(wei)基礎，以(yi)“產(chan)業＋金(jin)融”雙輪驅動模式迅速發展的(de)控股(gu)(gu)型集團上(shang)市(shi)(shi)公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(si)。目前公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(si)是廣(guang)發證(zheng)(zheng)(zheng)券(quan)(quan)股(gu)(gu)份有(you)限(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(si)（證(zheng)(zheng)(zheng)券(quan)(quan)簡(jian)稱：廣(guang)發證(zheng)(zheng)(zheng)券(quan)(quan)，證(zheng)(zheng)(zheng)券(quan)(quan)代(dai)(dai)碼：000776.SZ，1776.HK）的(de)大(da)股(gu)(gu)東(dong)，同(tong)時(shi)投資遼寧(ning)成(cheng)(cheng)大(da)股(gu)(gu)份有(you)限(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(si)（證(zheng)(zheng)(zheng)券(quan)(quan)簡(jian)稱：遼寧(ning)成(cheng)(cheng)大(da)，證(zheng)(zheng)(zheng)券(quan)(quan)代(dai)(dai)碼：600739）、上(shang)海(hai)第(di)一醫(yi)(yi)藥(yao)股(gu)(gu)份有(you)限(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(si)（證(zheng)(zheng)(zheng)券(quan)(quan)簡(jian)稱：第(di)一醫(yi)(yi)藥(yao)，證(zheng)(zheng)(zheng)券(quan)(quan)代(dai)(dai)碼：600833.SH）、吉林(lin)亞泰(集團)股(gu)(gu)份有(you)限(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(si)（證(zheng)(zheng)(zheng)券(quan)(quan)簡(jian)稱：亞泰集團，證(zheng)(zheng)(zheng)券(quan)(quan)代(dai)(dai)碼：600881.SH）、南(nan)京(jing)醫(yi)(yi)藥(yao)股(gu)(gu)份有(you)限(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(si)（證(zheng)(zheng)(zheng)券(quan)(quan)簡(jian)稱：南(nan)京(jing)醫(yi)(yi)藥(yao)，證(zheng)(zheng)(zheng)券(quan)(quan)代(dai)(dai)碼：600713.SH）、吉林(lin)博雅特(te)醫(yi)(yi)營(ying)養(yang)科技有(you)限(xian)(xian)公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)(si)等。

公司產品(pin)“安神補腦液(ye)(ye)(ye)”、“注(zhu)射用核糖核酸II”、“小(xiao)牛脾提取物注(zhu)射液(ye)(ye)(ye)”、“血(xue)(xue)府逐(zhu)瘀口(kou)(kou)服(fu)(fu)液(ye)(ye)(ye)”、“腦心(xin)(xin)舒口(kou)(kou)服(fu)(fu)液(ye)(ye)(ye)”、“小(xiao)兒(er)柴桂退(tui)熱口(kou)(kou)服(fu)(fu)液(ye)(ye)(ye)”、“養(yang)血(xue)(xue)飲(yin)口(kou)(kou)服(fu)(fu)液(ye)(ye)(ye)”、“心(xin)(xin)腦舒通膠囊(nang)”、“羚(ling)貝止咳(ke)糖漿”、“利腦心(xin)(xin)膠囊(nang)”、“少腹(fu)逐(zhu)瘀顆(ke)粒(li)”、“腎(shen)復康片(pian)”、“賴氨匹林”、“復方二氯醋酸二異丙胺注(zhu)射液(ye)(ye)(ye)”、“孕(yun)康顆(ke)粒(li)”、“根痛平丸”、“伸筋片(pian)”、“澳泰樂膠囊(nang)”、“鹿胎顆(ke)粒(li)”、“注(zhu)射用單磷(lin)酸阿(a)糖腺苷”、“小(xiao)兒(er)氨酚黃(huang)那敏顆(ke)粒(li)”、“中(zhong)風再造(zao)丸”等以質量穩定、療(liao)效(xiao)明顯(xian)受到市場一致好評，促進(jin)了公司醫(yi)藥主(zhu)業(ye)不斷發展壯(zhuang)大(da)。

公司秉持“專注(zhu)于人，專精于藥(yao)”的(de)(de)核心價(jia)值觀，堅(jian)持“大(da)品種(zhong)群(qun)、多(duo)品種(zhong)群(qun)”齊(qi)頭并進的(de)(de)醫藥(yao)產業發(fa)展(zhan)(zhan)戰略，堅(jian)持走“產業+金融”雙輪驅動(dong)的(de)(de)發(fa)展(zhan)(zhan)道(dao)路，順(shun)應醫藥(yao)行業發(fa)展(zhan)(zhan)趨勢(shi)，積極發(fa)揮自身(shen)優勢(shi)，夯實穩(wen)健發(fa)展(zhan)(zhan)的(de)(de)局面，努(nu)力實現“為社會提供安全、可(ke)信、放(fang)心藥(yao)”的(de)(de)企業使命。